Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after anti-thymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation

Epstein Barr viremia (EBV) and posttransplantation lymphoproliferative disorder (PTLD) are complications of hematopoietic stem cell transplantation (HSCT). The use of antithymocyte globulin in recipients of umbilical cord HSCT is a known risk factor for the development of PTLD. In this high risk pop...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Blaes, Anne H., Cao, Qing, Wagner, John E., Young, Jo-Anne H., Weisdorf, Daniel J., Brunstein, Claudio G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4113553/
https://ncbi.nlm.nih.gov/pubmed/19835968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.10.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak